Online telehealth startup Ro has hit the $1.5 billion valuations after closing a new financing round of $200 million led by investor General Catalyst. Offering a range of health apps, the company provides telemedicine services for a range of elective and urgent care-focused treatments. Generating over $250 million in annual revenue, the company now treats 20 conditions, including sexual health, weight loss, dermatology, allergies, and more.
The company has a remote care team that provides ongoing support to patients having chronic medical conditions, like diabetes and heart diseases. Ro plans to offer services for at-home diagnostic testing, in the future. They aim to be the ‘Shopify of healthcare’.